In a significant development, former U. S. Director of National Intelligence Tulsi Gabbard revealed that the United States has funded 120 biological labs in 30 countries, including Ukraine. This announcement comes after years of controversy regarding the potential risks associated with these labs, particularly concerning dangerous pathogens.
• Background Context: In 2022, Tulsi Gabbard raised concerns about U. S. funding of bio-research labs abroad, specifically in Ukraine. She faced criticism from politicians like Mitt Romney, who labeled her claims as "treasonous lies" and alleged Russian propaganda.
• Declassification of Information: In June 2026, Gabbard declassified information confirming that the U. S. indeed supported numerous bio-labs, some of which conducted research involving dangerous pathogens and gain-of-function techniques. This disclosure indicated that Ukraine was home to several of these labs.
• Research and Risks: The released documents indicated that the labs in Ukraine were working with highly dangerous pathogens, including those that cause anthrax, tuberculosis, SARS, and Ebola. Concerns were raised that if Russia gained control of these facilities, the pathogens could be misused as biological weapons.
• Reactions to the Revelation: Gabbard's announcement received praise from various quarters, including some Republican lawmakers and figures in medical science, who viewed it as a validation of previously dismissed claims regarding biological research activities in Ukraine.
• Media Coverage: The legacy media, including The New York Times, previously downplayed concerns about bio-labs, suggesting they were based on misinformation. Reports from March 2022 asserted that the U. S. was not funding biological weapons labs, contradicting Gabbard's assertions. Despite that, Gabbard's declassification lent credibility to her claims, reversing the narrative that had painted her as spreading conspiracy theories.
• Censorship and Misinformation: The article references a trend of censorship that labeled legitimate concerns as misinformation. Instances were noted where the media ridiculed allegations of biological labs being funded by the U. S., contrary to the reality now revealed by Gabbard's documents.
Tulsi Gabbard's revelation about U. S. funding of bio-labs marks a turning point in the discussion about foreign biological research and its associated risks. Her actions challenge previous narratives and highlight the tensions between government claims and the concerns raised by skeptics. This situation underscores the importance of transparency and rigorous debate on national security issues, especially those concerning public health and safety in volatile regions.